There has been a flood of interest about the experimental serum used to treat the American Ebola patients, so the Centers for Disease Control and Prevention just released their answers to common questions that have been popping up. For example:
They basically outline that this treatment is still very much at the pre-human phase of clinical trial development, and so it's a long way off from reaching patients. You can read more here.
This effort is part of CDC's response to public interest and anxiety over Ebola. Time magazine reported that there has been a flurry of worried callers to the agency over Ebola in recent weeks. "We've triaged those calls and about half-dozen or so resulted in specimen coming to CDC for testing and all have been negative for Ebola," CDC spokesman Tom Skinner told Time.
We're here to shed some clarity
One of our core beliefs here at Vox is that everyone needs and deserves access to the information that helps them understand the world, regardless of whether they can pay for a subscription. With the 2024 election on the horizon, more people are turning to us for clear and balanced explanations of the issues and policies at stake. We’re so grateful that we’re on track to hit 85,000 contributions to the Vox Contributions program before the end of the year, which in turn helps us keep this work free. We need to add 2,500 contributions this month to hit that goal.
Will you make a contribution today to help us hit this goal and support our policy coverage? Any amount helps.
Yes, I'll give $5/month
Yes, I'll give $5/month
We accept credit card, Apple Pay, and
Google Pay. You can also contribute via
:format(webp)/cdn.vox-cdn.com/uploads/chorus_image/image/36576352/453210018.0.jpg)
